Skip to content

Guidelines for radiation dose reporting in rectal cancer

GI GEC rectal brachy dose reporting project - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/102928
Enrollment
100
Registered
2026-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D- Radiation Therapy

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Maastricht Radiation Oncology Maastro Clinic
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Rectal cancer patients who have been treated with rectal high dose rate brachytherapy at participating centers. Availability of complete treatment planning data including dose volume histogram information. Treatment plans generated using clinically approved treatment planning systems. Cases where target and relevant structures are delineated according to the specified delineation guideline or can be updated accordingly.

Exclusion criteria

Exclusion criteria: Cases with incomplete or missing treatment planning or dose volume histogram data. Treatment plans not suitable for dose volume histogram analysis due to technical limitations. Cases where required delineation structures are unavailable and cannot be reconstructed or updated.

Design outcomes

Primary

MeasureTime frame
Identification of robust dose volume and depth dose metrics for rectal high dose rate brachytherapy that are sensitive to clinically relevant variations in dose distribution and remain stable across contouring variability and treatment planning system differencesTimepoint: Not applicable

Secondary

MeasureTime frame
To evaluate inter-centre variability in contemporary clinical practice; assess the sensitivity of dosimetric outcomes to unavoidable target delineation uncertainties; examine susceptibility to variations in DVH calculation methods, treatment planning system software, & minor source positional deviations; & determine the feasibility of categorizing robust dosimetric metrics into entry-level, advanced-level, & research-level dose reporting frameworksTimepoint: Not applicable

Countries

India

Contacts

Public ContactRahul Krishnatry

Tata Memorial

krishnatry@gmail.com02224177028

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026